DocGo Inc.
DocGo Inc. (DCGO) Stock Competitors & Peer Comparison
See (DCGO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DCGO | $0.74 | -6.47% | 72.5M | -1.40 | -$0.53 | N/A |
| HCA | $525.91 | -1.20% | 119.8B | 18.91 | $28.34 | +0.54% |
| THC | $235.58 | +2.47% | 20.6B | 15.91 | $14.71 | N/A |
| UHS | $230.40 | -0.04% | 15B | 11.08 | $21.00 | +0.34% |
| FMS | $22.95 | -5.87% | 14.4B | 16.97 | $1.45 | +3.21% |
| SOLV | $73.49 | +0.75% | 12.6B | 8.34 | $8.71 | N/A |
| ENSG | $212.52 | +0.89% | 12.4B | 36.67 | $5.84 | +0.12% |
| EHC | $105.37 | -1.11% | 10.7B | 19.12 | $5.55 | +0.68% |
| DVA | $149.15 | -1.05% | 10.1B | 15.91 | $9.51 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
DCGO vs HCA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, HCA has a market cap of 119.8B. Regarding current trading prices, DCGO is priced at $0.74, while HCA trades at $525.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas HCA's P/E ratio is 18.91. In terms of profitability, DCGO's ROE is -0.17%, compared to HCA's ROE of -1.41%. Regarding short-term risk, DCGO is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check HCA's competition here
DCGO vs THC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, THC has a market cap of 20.6B. Regarding current trading prices, DCGO is priced at $0.74, while THC trades at $235.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas THC's P/E ratio is 15.91. In terms of profitability, DCGO's ROE is -0.17%, compared to THC's ROE of +0.35%. Regarding short-term risk, DCGO is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check THC's competition here
DCGO vs UHS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, UHS has a market cap of 15B. Regarding current trading prices, DCGO is priced at $0.74, while UHS trades at $230.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas UHS's P/E ratio is 11.08. In terms of profitability, DCGO's ROE is -0.17%, compared to UHS's ROE of +0.20%. Regarding short-term risk, DCGO is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check UHS's competition here
DCGO vs FMS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, FMS has a market cap of 14.4B. Regarding current trading prices, DCGO is priced at $0.74, while FMS trades at $22.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas FMS's P/E ratio is 16.97. In terms of profitability, DCGO's ROE is -0.17%, compared to FMS's ROE of +0.05%. Regarding short-term risk, DCGO is less volatile compared to FMS. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check FMS's competition here
DCGO vs SOLV Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SOLV has a market cap of 12.6B. Regarding current trading prices, DCGO is priced at $0.74, while SOLV trades at $73.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SOLV's P/E ratio is 8.34. In terms of profitability, DCGO's ROE is -0.17%, compared to SOLV's ROE of +0.41%. Regarding short-term risk, DCGO is less volatile compared to SOLV. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check SOLV's competition here
DCGO vs ENSG Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ENSG has a market cap of 12.4B. Regarding current trading prices, DCGO is priced at $0.74, while ENSG trades at $212.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ENSG's P/E ratio is 36.67. In terms of profitability, DCGO's ROE is -0.17%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, DCGO is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check ENSG's competition here
DCGO vs EHC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, EHC has a market cap of 10.7B. Regarding current trading prices, DCGO is priced at $0.74, while EHC trades at $105.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas EHC's P/E ratio is 19.12. In terms of profitability, DCGO's ROE is -0.17%, compared to EHC's ROE of +0.23%. Regarding short-term risk, DCGO is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check EHC's competition here
DCGO vs DVA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, DVA has a market cap of 10.1B. Regarding current trading prices, DCGO is priced at $0.74, while DVA trades at $149.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas DVA's P/E ratio is 15.91. In terms of profitability, DCGO's ROE is -0.17%, compared to DVA's ROE of -1.61%. Regarding short-term risk, DCGO is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check DVA's competition here
DCGO vs OSH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, DCGO is priced at $0.74, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas OSH's P/E ratio is -17.65. In terms of profitability, DCGO's ROE is -0.17%, compared to OSH's ROE of +4.64%. Regarding short-term risk, DCGO is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check OSH's competition here
DCGO vs CHE Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CHE has a market cap of 7B. Regarding current trading prices, DCGO is priced at $0.74, while CHE trades at $472.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CHE's P/E ratio is 25.35. In terms of profitability, DCGO's ROE is -0.17%, compared to CHE's ROE of +0.24%. Regarding short-term risk, DCGO is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check CHE's competition here
DCGO vs OPCH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, OPCH has a market cap of 5.9B. Regarding current trading prices, DCGO is priced at $0.74, while OPCH trades at $34.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas OPCH's P/E ratio is 28.64. In terms of profitability, DCGO's ROE is -0.17%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, DCGO is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check OPCH's competition here
DCGO vs LHCG Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, DCGO is priced at $0.74, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas LHCG's P/E ratio is 82.83. In terms of profitability, DCGO's ROE is -0.17%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, DCGO is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check LHCG's competition here
DCGO vs BKD Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, BKD has a market cap of 3.7B. Regarding current trading prices, DCGO is priced at $0.74, while BKD trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas BKD's P/E ratio is -11.69. In terms of profitability, DCGO's ROE is -0.17%, compared to BKD's ROE of -5.24%. Regarding short-term risk, DCGO is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check BKD's competition here
DCGO vs AMED Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, DCGO is priced at $0.74, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AMED's P/E ratio is 39.30. In terms of profitability, DCGO's ROE is -0.17%, compared to AMED's ROE of +0.13%. Regarding short-term risk, DCGO is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check AMED's competition here
DCGO vs LFST Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, LFST has a market cap of 2.8B. Regarding current trading prices, DCGO is priced at $0.74, while LFST trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas LFST's P/E ratio is -236.33. In terms of profitability, DCGO's ROE is -0.17%, compared to LFST's ROE of -0.01%. Regarding short-term risk, DCGO is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check LFST's competition here
DCGO vs NHC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, NHC has a market cap of 2.4B. Regarding current trading prices, DCGO is priced at $0.74, while NHC trades at $157.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas NHC's P/E ratio is 24.27. In terms of profitability, DCGO's ROE is -0.17%, compared to NHC's ROE of +0.10%. Regarding short-term risk, DCGO is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check NHC's competition here
DCGO vs ADUS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, DCGO is priced at $0.74, while ADUS trades at $107.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ADUS's P/E ratio is 25.19. In terms of profitability, DCGO's ROE is -0.17%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, DCGO is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check ADUS's competition here
DCGO vs SGRY Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, DCGO is priced at $0.74, while SGRY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SGRY's P/E ratio is -11.39. In terms of profitability, DCGO's ROE is -0.17%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, DCGO is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check SGRY's competition here
DCGO vs SEM Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SEM has a market cap of 1.8B. Regarding current trading prices, DCGO is priced at $0.74, while SEM trades at $14.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SEM's P/E ratio is 18.04. In terms of profitability, DCGO's ROE is -0.17%, compared to SEM's ROE of +0.09%. Regarding short-term risk, DCGO is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check SEM's competition here
DCGO vs AMEH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, DCGO is priced at $0.74, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AMEH's P/E ratio is 39.25. In terms of profitability, DCGO's ROE is -0.17%, compared to AMEH's ROE of +0.02%. Regarding short-term risk, DCGO is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AMEH's competition here
DCGO vs MD Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, MD has a market cap of 1.7B. Regarding current trading prices, DCGO is priced at $0.74, while MD trades at $19.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas MD's P/E ratio is 10.34. In terms of profitability, DCGO's ROE is -0.17%, compared to MD's ROE of +0.20%. Regarding short-term risk, DCGO is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check MD's competition here
DCGO vs ACHC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ACHC has a market cap of 1.6B. Regarding current trading prices, DCGO is priced at $0.74, while ACHC trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ACHC's P/E ratio is 14.98. In terms of profitability, DCGO's ROE is -0.17%, compared to ACHC's ROE of +0.03%. Regarding short-term risk, DCGO is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check ACHC's competition here
DCGO vs AVAH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AVAH has a market cap of 1.5B. Regarding current trading prices, DCGO is priced at $0.74, while AVAH trades at $7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AVAH's P/E ratio is 19.46. In terms of profitability, DCGO's ROE is -0.17%, compared to AVAH's ROE of -1.36%. Regarding short-term risk, DCGO is more volatile compared to AVAH. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check AVAH's competition here
DCGO vs HCSG Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, DCGO is priced at $0.74, while HCSG trades at $20.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas HCSG's P/E ratio is 25.69. In terms of profitability, DCGO's ROE is -0.17%, compared to HCSG's ROE of +0.12%. Regarding short-term risk, DCGO is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check HCSG's competition here
DCGO vs ARDT Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ARDT has a market cap of 1.4B. Regarding current trading prices, DCGO is priced at $0.74, while ARDT trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ARDT's P/E ratio is 6.57. In terms of profitability, DCGO's ROE is -0.17%, compared to ARDT's ROE of +0.17%. Regarding short-term risk, DCGO is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check ARDT's competition here
DCGO vs USPH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, DCGO is priced at $0.74, while USPH trades at $82.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas USPH's P/E ratio is 35.27. In terms of profitability, DCGO's ROE is -0.17%, compared to USPH's ROE of +0.07%. Regarding short-term risk, DCGO is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check USPH's competition here
DCGO vs BKDT Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, DCGO is priced at $0.74, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas BKDT's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to BKDT's ROE of -5.24%. Regarding short-term risk, DCGO is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check BKDT's competition here
DCGO vs INNV Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, DCGO is priced at $0.74, while INNV trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas INNV's P/E ratio is 178.40. In terms of profitability, DCGO's ROE is -0.17%, compared to INNV's ROE of -0.02%. Regarding short-term risk, DCGO is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check INNV's competition here
DCGO vs PNTG Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, PNTG has a market cap of 1.1B. Regarding current trading prices, DCGO is priced at $0.74, while PNTG trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas PNTG's P/E ratio is 43.41. In terms of profitability, DCGO's ROE is -0.17%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, DCGO is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check PNTG's competition here
DCGO vs ASTH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ASTH has a market cap of 994.1M. Regarding current trading prices, DCGO is priced at $0.74, while ASTH trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ASTH's P/E ratio is 104.32. In terms of profitability, DCGO's ROE is -0.17%, compared to ASTH's ROE of +0.01%. Regarding short-term risk, DCGO is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check ASTH's competition here
DCGO vs FSHCX Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, FSHCX has a market cap of 808M. Regarding current trading prices, DCGO is priced at $0.74, while FSHCX trades at $100.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas FSHCX's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to FSHCX's ROE of N/A. Regarding short-term risk, DCGO is more volatile compared to FSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check FSHCX's competition here
DCGO vs AMN Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AMN has a market cap of 799.8M. Regarding current trading prices, DCGO is priced at $0.74, while AMN trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AMN's P/E ratio is -2.89. In terms of profitability, DCGO's ROE is -0.17%, compared to AMN's ROE of -0.15%. Regarding short-term risk, DCGO is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AMN's competition here
DCGO vs TALK Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TALK has a market cap of 773.7M. Regarding current trading prices, DCGO is priced at $0.74, while TALK trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TALK's P/E ratio is 154.00. In terms of profitability, DCGO's ROE is -0.17%, compared to TALK's ROE of +0.07%. Regarding short-term risk, DCGO is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check TALK's competition here
DCGO vs CMPS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CMPS has a market cap of 753.6M. Regarding current trading prices, DCGO is priced at $0.74, while CMPS trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CMPS's P/E ratio is -2.89. In terms of profitability, DCGO's ROE is -0.17%, compared to CMPS's ROE of -1.72%. Regarding short-term risk, DCGO and CMPS have similar daily volatility (2.27).Check CMPS's competition here
DCGO vs EHAB Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, EHAB has a market cap of 689.4M. Regarding current trading prices, DCGO is priced at $0.74, while EHAB trades at $13.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas EHAB's P/E ratio is -56.67. In terms of profitability, DCGO's ROE is -0.17%, compared to EHAB's ROE of -0.02%. Regarding short-term risk, DCGO is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check EHAB's competition here
DCGO vs SNDA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SNDA has a market cap of 649.3M. Regarding current trading prices, DCGO is priced at $0.74, while SNDA trades at $35.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SNDA's P/E ratio is -11.57. In terms of profitability, DCGO's ROE is -0.17%, compared to SNDA's ROE of -0.44%. Regarding short-term risk, DCGO is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check SNDA's competition here
DCGO vs CYH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CYH has a market cap of 460.6M. Regarding current trading prices, DCGO is priced at $0.74, while CYH trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CYH's P/E ratio is 1.36. In terms of profitability, DCGO's ROE is -0.17%, compared to CYH's ROE of -0.32%. Regarding short-term risk, DCGO is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check CYH's competition here
DCGO vs MCTA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, DCGO is priced at $0.74, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas MCTA's P/E ratio is 419.36. In terms of profitability, DCGO's ROE is -0.17%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, DCGO is more volatile compared to MCTA. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check MCTA's competition here
DCGO vs AUNA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AUNA has a market cap of 378.4M. Regarding current trading prices, DCGO is priced at $0.74, while AUNA trades at $5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AUNA's P/E ratio is 5.21. In terms of profitability, DCGO's ROE is -0.17%, compared to AUNA's ROE of +0.12%. Regarding short-term risk, DCGO is less volatile compared to AUNA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AUNA's competition here
DCGO vs AONC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AONC has a market cap of 351M. Regarding current trading prices, DCGO is priced at $0.74, while AONC trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AONC's P/E ratio is -13.48. In terms of profitability, DCGO's ROE is -0.17%, compared to AONC's ROE of -0.02%. Regarding short-term risk, DCGO is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check AONC's competition here
DCGO vs CCRN Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CCRN has a market cap of 280.8M. Regarding current trading prices, DCGO is priced at $0.74, while CCRN trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CCRN's P/E ratio is -17.49. In terms of profitability, DCGO's ROE is -0.17%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, DCGO is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check CCRN's competition here
DCGO vs TOI Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TOI has a market cap of 250.9M. Regarding current trading prices, DCGO is priced at $0.74, while TOI trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TOI's P/E ratio is -3.98. In terms of profitability, DCGO's ROE is -0.17%, compared to TOI's ROE of +21.04%. Regarding short-term risk, DCGO is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check TOI's competition here
DCGO vs CSU Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, DCGO is priced at $0.74, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CSU's P/E ratio is 0.67. In terms of profitability, DCGO's ROE is -0.17%, compared to CSU's ROE of -3.25%. Regarding short-term risk, DCGO is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check CSU's competition here
DCGO vs AGL Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AGL has a market cap of 180.1M. Regarding current trading prices, DCGO is priced at $0.74, while AGL trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AGL's P/E ratio is -0.56. In terms of profitability, DCGO's ROE is -0.17%, compared to AGL's ROE of -0.73%. Regarding short-term risk, DCGO is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AGL's competition here
DCGO vs JYNT Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, JYNT has a market cap of 138.7M. Regarding current trading prices, DCGO is priced at $0.74, while JYNT trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas JYNT's P/E ratio is -913.00. In terms of profitability, DCGO's ROE is -0.17%, compared to JYNT's ROE of -0.04%. Regarding short-term risk, DCGO is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check JYNT's competition here
DCGO vs NAKAW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, NAKAW has a market cap of 116.4M. Regarding current trading prices, DCGO is priced at $0.74, while NAKAW trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas NAKAW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to NAKAW's ROE of -0.74%. Regarding short-term risk, DCGO is less volatile compared to NAKAW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check NAKAW's competition here
DCGO vs AIRS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AIRS has a market cap of 103M. Regarding current trading prices, DCGO is priced at $0.74, while AIRS trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AIRS's P/E ratio is -5.50. In terms of profitability, DCGO's ROE is -0.17%, compared to AIRS's ROE of -0.22%. Regarding short-term risk, DCGO is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AIRS's competition here
DCGO vs FVE Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, DCGO is priced at $0.74, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas FVE's P/E ratio is -5.64. In terms of profitability, DCGO's ROE is -0.17%, compared to FVE's ROE of -0.15%. Regarding short-term risk, DCGO is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check FVE's competition here
DCGO vs BTMD Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, BTMD has a market cap of 98.1M. Regarding current trading prices, DCGO is priced at $0.74, while BTMD trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas BTMD's P/E ratio is 2.59. In terms of profitability, DCGO's ROE is -0.17%, compared to BTMD's ROE of -0.33%. Regarding short-term risk, DCGO is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check BTMD's competition here
DCGO vs KDLYW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, DCGO is priced at $0.74, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas KDLYW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to KDLYW's ROE of -0.74%. Regarding short-term risk, DCGO is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check KDLYW's competition here
DCGO vs ALR Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, DCGO is priced at $0.74, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ALR's P/E ratio is -1.11. In terms of profitability, DCGO's ROE is -0.17%, compared to ALR's ROE of -0.15%. Regarding short-term risk, DCGO is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check ALR's competition here
DCGO vs IMAC Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, DCGO is priced at $0.74, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas IMAC's P/E ratio is -2.27. In terms of profitability, DCGO's ROE is -0.17%, compared to IMAC's ROE of +1183.61%. Regarding short-term risk, DCGO is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check IMAC's competition here
DCGO vs CCEL Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CCEL has a market cap of 27.4M. Regarding current trading prices, DCGO is priced at $0.74, while CCEL trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CCEL's P/E ratio is -56.67. In terms of profitability, DCGO's ROE is -0.17%, compared to CCEL's ROE of -0.03%. Regarding short-term risk, DCGO is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check CCEL's competition here
DCGO vs AIH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, DCGO is priced at $0.74, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AIH's P/E ratio is -2.78. In terms of profitability, DCGO's ROE is -0.17%, compared to AIH's ROE of +1.16%. Regarding short-term risk, DCGO is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AIH's competition here
DCGO vs AMS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, AMS has a market cap of 14M. Regarding current trading prices, DCGO is priced at $0.74, while AMS trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas AMS's P/E ratio is -6.09. In terms of profitability, DCGO's ROE is -0.17%, compared to AMS's ROE of -0.09%. Regarding short-term risk, DCGO is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check AMS's competition here
DCGO vs CANO Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, DCGO is priced at $0.74, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CANO's P/E ratio is -0.01. In terms of profitability, DCGO's ROE is -0.17%, compared to CANO's ROE of -1.49%. Regarding short-term risk, DCGO is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check CANO's competition here
DCGO vs FTRP Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, DCGO is priced at $0.74, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas FTRP's P/E ratio is -1.22. In terms of profitability, DCGO's ROE is -0.17%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, DCGO is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check FTRP's competition here
DCGO vs TOIIW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TOIIW has a market cap of 7.4M. Regarding current trading prices, DCGO is priced at $0.74, while TOIIW trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TOIIW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to TOIIW's ROE of +21.04%. Regarding short-term risk, DCGO is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check TOIIW's competition here
DCGO vs PIII Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, PIII has a market cap of 7M. Regarding current trading prices, DCGO is priced at $0.74, while PIII trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas PIII's P/E ratio is -0.04. In terms of profitability, DCGO's ROE is -0.17%, compared to PIII's ROE of -3.18%. Regarding short-term risk, DCGO is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check PIII's competition here
DCGO vs MODV Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, DCGO is priced at $0.74, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas MODV's P/E ratio is -0.03. In terms of profitability, DCGO's ROE is -0.17%, compared to MODV's ROE of +1.84%. Regarding short-term risk, DCGO is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check MODV's competition here
DCGO vs GBNH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, DCGO is priced at $0.74, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas GBNH's P/E ratio is -0.06. In terms of profitability, DCGO's ROE is -0.17%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, DCGO is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check GBNH's competition here
DCGO vs RHE Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, DCGO is priced at $0.74, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas RHE's P/E ratio is -1.79. In terms of profitability, DCGO's ROE is -0.17%, compared to RHE's ROE of +0.06%. Regarding short-term risk, DCGO is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check RHE's competition here
DCGO vs RHE-PA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, DCGO is priced at $0.74, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, DCGO's ROE is -0.17%, compared to RHE-PA's ROE of -0.04%. Regarding short-term risk, DCGO is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check RHE-PA's competition here
DCGO vs TALKW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TALKW has a market cap of 3.5M. Regarding current trading prices, DCGO is priced at $0.74, while TALKW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TALKW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to TALKW's ROE of +0.07%. Regarding short-term risk, DCGO is more volatile compared to TALKW. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check TALKW's competition here
DCGO vs ATIP Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, DCGO is priced at $0.74, while ATIP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas ATIP's P/E ratio is -0.03. In terms of profitability, DCGO's ROE is -0.17%, compared to ATIP's ROE of +0.23%. Regarding short-term risk, DCGO is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check ATIP's competition here
DCGO vs IMACW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, DCGO is priced at $0.74, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas IMACW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to IMACW's ROE of +1.05%. Regarding short-term risk, DCGO is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check IMACW's competition here
DCGO vs SYRA Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SYRA has a market cap of 1M. Regarding current trading prices, DCGO is priced at $0.74, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SYRA's P/E ratio is -1.12. In terms of profitability, DCGO's ROE is -0.17%, compared to SYRA's ROE of -0.51%. Regarding short-term risk, DCGO is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check SYRA's competition here
DCGO vs MNDR Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, MNDR has a market cap of 822.9K. Regarding current trading prices, DCGO is priced at $0.74, while MNDR trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas MNDR's P/E ratio is -0.05. In terms of profitability, DCGO's ROE is -0.17%, compared to MNDR's ROE of -1.29%. Regarding short-term risk, DCGO is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check MNDR's competition here
DCGO vs CCM Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, CCM has a market cap of 500.9K. Regarding current trading prices, DCGO is priced at $0.74, while CCM trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas CCM's P/E ratio is -0.63. In terms of profitability, DCGO's ROE is -0.17%, compared to CCM's ROE of +0.07%. Regarding short-term risk, DCGO is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check CCM's competition here
DCGO vs BACK Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, BACK has a market cap of 227.1K. Regarding current trading prices, DCGO is priced at $0.74, while BACK trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas BACK's P/E ratio is -0.02. In terms of profitability, DCGO's ROE is -0.17%, compared to BACK's ROE of +1.05%. Regarding short-term risk, DCGO is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check BACK's competition here
DCGO vs NVOS Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, NVOS has a market cap of 69.1K. Regarding current trading prices, DCGO is priced at $0.74, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas NVOS's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to NVOS's ROE of -0.81%. Regarding short-term risk, DCGO is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check NVOS's competition here
DCGO vs NIVFW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, NIVFW has a market cap of 35.3K. Regarding current trading prices, DCGO is priced at $0.74, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas NIVFW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to NIVFW's ROE of +1.17%. Regarding short-term risk, DCGO is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check NIVFW's competition here
DCGO vs PIIIW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, PIIIW has a market cap of 19.6K. Regarding current trading prices, DCGO is priced at $0.74, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas PIIIW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to PIIIW's ROE of -3.18%. Regarding short-term risk, DCGO is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check PIIIW's competition here
DCGO vs IONM Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, IONM has a market cap of 313. Regarding current trading prices, DCGO is priced at $0.74, while IONM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas IONM's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to IONM's ROE of +5.28%. Regarding short-term risk, DCGO is more volatile compared to IONM. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check IONM's competition here
DCGO vs TVTY Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TVTY's P/E ratio is 19.06. In terms of profitability, DCGO's ROE is -0.17%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, DCGO is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check TVTY's competition here
DCGO vs DCGOW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas DCGOW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to DCGOW's ROE of -0.17%. Regarding short-term risk, DCGO is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check DCGOW's competition here
DCGO vs TLMDW Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TLMDW's P/E ratio is N/A. In terms of profitability, DCGO's ROE is -0.17%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, DCGO is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check TLMDW's competition here
DCGO vs TLMD Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas TLMD's P/E ratio is -1.60. In terms of profitability, DCGO's ROE is -0.17%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, DCGO is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check TLMD's competition here
DCGO vs SLHGP Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, DCGO's ROE is -0.17%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, DCGO is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check SLHGP's competition here
DCGO vs HNGR Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas HNGR's P/E ratio is 19.71. In terms of profitability, DCGO's ROE is -0.17%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, DCGO is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check HNGR's competition here
DCGO vs DVCR Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas DVCR's P/E ratio is 28.34. In terms of profitability, DCGO's ROE is -0.17%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, DCGO is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check DVCR's competition here
DCGO vs SLHG Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas SLHG's P/E ratio is -1.48. In terms of profitability, DCGO's ROE is -0.17%, compared to SLHG's ROE of N/A. Regarding short-term risk, DCGO is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for DCGO.Check SLHG's competition here
DCGO vs NFH Comparison February 2026
DCGO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCGO stands at 72.5M. In comparison, NFH has a market cap of 0. Regarding current trading prices, DCGO is priced at $0.74, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCGO currently has a P/E ratio of -1.40, whereas NFH's P/E ratio is -19.75. In terms of profitability, DCGO's ROE is -0.17%, compared to NFH's ROE of -0.06%. Regarding short-term risk, DCGO is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for DCGO.Check NFH's competition here